Found 1009 clinical trials
TRANSFORM – B cell non-Hodgkin lymphoma - JCAR017-BCM-003 - US
) aggressive Non-Hodgkin lymphoma (NHL) to compare safety and efficacy between the standard of care (SOC) strategy versus JCAR017 (also known as lisocabtagene maraleucel or liso-cel). Subjects will be randomized
- 2946 views
- 05 Jan, 2021
- 10 locations
-
Unknown Phase
-
Accepting pediatric ages
-
Accepting adults
-
Currently Recruiting
Phase 1/2 Study Of Intratumoral G100 With Or Without Pembrolizumab In Patients With Follicular Non-Hodgkin’s Lymphoma
Phase 1/2 Study Of Intratumoral G100 With Or Without Pembrolizumab In Patients With Follicular Non-Hodgkin’s Lymphoma
- 590 views
- 23 Nov, 2020
- 5 locations
TRANSCEND - Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL) - TRANSCEND-CLL-004 - US
Phase 2 single-arm, multi-cohort study to determine the efficacy and safety of JCAR017 (autologous T cells expressing anti-CD19 chimeric antigen receptor) in adult subjects with aggressive B-NHL (diffuse large B-cell lymphoma (DLBCL) NOS [de novo or transformed follicular lymphoma (tFL)], double/triple-hit lymphoma [DHL/THL], follicular lymphoma Grade 3B [FL3B], primary central …
- 1875 views
- 15 Jan, 2021
- 15 locations
-
Unknown Phase
-
Accepting Seniors
-
Accepting adults
-
Currently Recruiting
A Prospective, Multi-Center, Randomized, Controlled, Pivotal Trial to Validate the Safety and Efficacy of the Hemolung® Respiratory Assist System for COPD Patients Experiencing an Acute Exacerbation Requiring Ventilatory Support (Protocol No. HL-CA-5000)
Exacerbation Requiring Ventilatory Support (Protocol No. HL-CA-5000)
- 36 views
- 11 Jun, 2020
- 1 location
-
Multi-country trial
-
Phase 1 trial
-
Accepting Seniors
-
Accepting adults
-
Oncology
-
Currently Recruiting
Phase 1/2 Study Of Intratumoral G100 With Or Without Pembrolizumab or Rituximab In Patients With Follicular Non-Hodgkin’s Lymphoma
This is a multi-center Phase 1/2 open label trial of intratumoral G100 in patients with low grade NHL. Patients with NHL will be enrolled and receive G100 to an accessable tumor mass. Clinical response will be evaluated in the injected lesion and systemic (abscopal) responses will be evaluated in distal …
- 73 views
- 22 Dec, 2020
- 31 locations
-
Phase 1 trial
-
Accepting Seniors
-
Accepting adults
-
Currently Recruiting
HERV-E TCR Transduced Autologous T Cells in People With Metastatic Clear Cell Renal Cell Carcinoma
of agents such as VEGF, mTOR inhibitors and immunotherapy (high-dose (HD) IL-2 or immune-checkpoint inhibitors). Long-term survival can be achieved with high-doses IL-2 or immune-checkpoint inhibitors
- 144 views
- 22 Dec, 2020
- 1 location
-
Unknown Phase
-
Accepting pediatric ages
-
Accepting adults
-
Currently Recruiting
Diffuse Large B Cell/Non-Hodgkin Lymphoma
Diffuse Large B Cell/Non-Hodgkin Lymphoma
- 902 views
- 08 Nov, 2020
- 1 location
PILOT - B cell non-Hodgkin lymphoma - TRANSCEND-PILOT-017006 - US
single line of immunochemotherapy for aggressive B-cell non-Hodgkin lymphoma (NHL) and are ineligible for hematopoietic stem cell transplant (based on age, performance status, and/or comorbidities
- 2758 views
- 15 Dec, 2020
- 12 locations
-
Unknown Phase
-
Accepting Seniors
-
Accepting adults
-
Family Medicine
-
Currently Recruiting
Chronic Lymphocytic Leukemia / Small Lymphocytic Lymphoma (C/SLL) or Non-Hodgkin Lymphoma (NHL)
People with previously treated Lymphomas are asked to participate in a research study being conducted by Northwell Health.
- 17 views
- 23 Jul, 2020
- 1 location
-
Unknown Phase
-
Accepting pediatric ages
-
Accepting adults
-
Currently Recruiting
Hodgkin Lymphoma Molecular Profiling and Clinical Outcomes in U.S. Community Oncology Practices
Hodgkin Lymphoma Molecular Profiling and Clinical Outcomes in U.S. Community Oncology Practices
- 8 views
- 08 Nov, 2020
- 1 location